Science Explorer Interactive view Map
Company · Osaka · Japan

Fujimoto Pharmaceutical Corporation (Japan)

fujimoto-pharm.co.jpROR OpenAlex
Research works
54
▲ 20% vs 2013–17
Citations
712
13.1 per fractional work
Top-10% rate
0.0%
record average 16.5%
Open access
39%
world 28%

Not ranked overall: Fujimoto Pharmaceutical Corporation (Japan) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Which keywords describe research at Fujimoto Pharmaceutical Corporation (Japan)?

By fractional works in all years, weighted toward what it does more of than the world: Oxidative Stress, Synaptic Plasticity, Neurodegeneration, Neurological Disorders, Mitochondrial Dysfunction, Synthesis, Parkinson's Disease and Drug Discovery.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Oxidative Stress7▲ 6.7×12 topics
  2. Inflammation4▲ 3.5×15 topics
  3. Neurodegeneration4▲ 25×6 topics
  4. Neurological Disorders4▲ 11×4 topics
  5. Synaptic Plasticity4▲ 25×2 topics
  6. Mitochondrial Dysfunction4▲ 18×6 topics
  7. Synthesis4▲ 12×8 topics
  8. Parkinson's Disease4▲ 29×3 topics
  9. Drug Discovery3▲ 16×6 topics
  10. Prefrontal Cortex3▲ 42×2 topics
  11. Stress3▲ 15×3 topics
  12. Depression3▲ 7.5×5 topics
  13. Genetic Variation3▲ 17×3 topics
  14. Dopaminergic Neurons3▲ 79×2 topics
  15. Dopamine3▲ 93×1 topic
  16. GABAergic3▲ 37×1 topic
  17. Neurotransmission3▲ 37×1 topic
  18. Serotonin3▲ 77×1 topic
  19. Antioxidant2▲ 6.8×5 topics
  20. Genetic Risk Factors2▲ 89×1 topic
  21. Heterocycles2▲ 24×4 topics
  22. Medicinal Chemistry2▲ 12×5 topics
  23. Pharmacology2▲ 13×3 topics
  24. a-Synuclein2▲ 89×1 topic
  25. Anticancer Agents2▲ 16×3 topics
  26. Neuroprotection2▲ 10×5 topics
  27. Anticancer2▲ 19×4 topics
  28. Alzheimer's Disease2▲ 12×5 topics
  29. Neurodegenerative Diseases2▲ 16×5 topics
  30. Neuroinflammation2▲ 13×4 topics
  31. Neuronal Plasticity2▲ 43×2 topics
  32. Organic Synthesis2▲ 16×8 topics
  33. Biological Evaluation2▲ 27×3 topics
  34. Antimicrobial2▲ 12×3 topics
  35. Reactive Oxygen Species2▲ 6.3×5 topics
  36. BDNF2▲ 91×1 topic
  37. Heterocyclic Compounds2▲ 18×3 topics
  38. Neurotrophins2▲ 91×1 topic
  39. Tumor Microenvironment2▲ 7.8×5 topics
  40. Transcriptional Regulation1▲ 11×5 topics

Which research topics does Fujimoto Pharmaceutical Corporation (Japan) publish most on?

By volume in 2022–2025: Protein Degradation and Inhibitors, Lymphoma Diagnosis and Treatment, Peptidase Inhibition and Analysis and Cell death mechanisms and regulation.

Protein Degradation and …1Protein Degradation and Inhibitors: 1 fractional worksLymphoma Diagnosis and T…0Lymphoma Diagnosis and Treatment: 0 fractional worksPeptidase Inhibition and…0Peptidase Inhibition and Analysis: 0 fractional worksCell death mechanisms an…0Cell death mechanisms and regulation: 0 fractional worksClick Chemistry and Appl…0Click Chemistry and Applications: 0 fractional worksFrailty in Older Adults: 0 fractional worksWireless Power Transfer Systems: 0 fractional worksCancer survivorship and care: 0 fractional worksMicrowave and Dielectric Measurement Techniques: 0 fractional worksPalliative Care and End-of-Life Issues: 0 fractional works
Molecular BiologyPathology and Forensic MedicineOncologyOrganic Chemistry3 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Protein Degradation and Inhibitors Molecular Biology 1 works
  2. 2 Lymphoma Diagnosis and Treatment Pathology and Forensic Medicine 0 works
  3. 3 Peptidase Inhibition and Analysis Oncology 0 works
  4. 4 Cell death mechanisms and regulation Molecular Biology 0 works
  5. 5 Click Chemistry and Applications Organic Chemistry 0 works
  6. 6 Frailty in Older Adults Geriatrics and Gerontology 0 works
  7. 7 Wireless Power Transfer Systems Electrical and Electronic Engineering 0 works
  8. 8 Cancer survivorship and care Oncology 0 works
  9. 9 Microwave and Dielectric Measurement Techniques Electrical and Electronic Engineering 0 works
  10. 10 Palliative Care and End-of-Life Issues Public Health, Environmental and Occupational Health 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available38.7%not open61.3%

World: 28% of research is openly available.

with international co-authors10.6%domestic only89.4%

World: 19% is written across borders.

How has Fujimoto Pharmaceutical Corporation (Japan)'s research output changed?

Output in 2018–2022 was 20% higher than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Osaka

All research institutions in Osaka

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.